Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJRS.L Regulatory News (JRS)

  • There is currently no data for JRS

Sanctions Update

1 Mar 2022 14:21

RNS Number : 2396D
JPMorgan Russian Securities PLC
01 March 2022
 

 

 

LONDON STOCK EXCHANGE ANNOUNCEMENT

 

 

JPMORGAN RUSSIAN SECURITIES PLC

 

Legal Entity Identifier: 549300II3MHI98ZLVH37

 

 

Update from the Board of JPMorgan Russian Securities plc

 

Further to JPMorgan Russian Securities plc's (the Company) announcement on 24th February 2022 regarding the US/EU/UK sanctions, the Board provides the following update:

 

Portfolio:

As at 28th February 2022, the Company's portfolio comprised holdings in locally listed stocks of 49.4%, which the Company is currently unable to trade due to recent restrictions. 40.1% of the Company's holdings are in ADR/GDRs, where trading is disrupted. 10.5% of the Company's assets are held in mostly US Dollar cash and cash equivalents.

The Company currently holds VTB Bank stocks which represented approximately 1.9% of the Company's portfolio as at 25th February 2022. The Company's Manager continues to monitor the impact of the developing sanctions regimes on these stocks.

 

Management Fees:

The Company's Manager has advised the Board of its intention to waive its management fee. The waiver will take effect following payment of the management fee to 28th February 2022 and will apply until further notice.

 

NAV:

The Company will continue to calculate and announce its unaudited NAV on a daily basis. Details of the methodology applied to the calculation of the unaudited NAV will be included in these announcements.

 

Dividends:

As previously announced, the Company will pay its final and first interim dividends to shareholders on 11th March 2022, as declared on 27th January 2022. However, the current sanctions and restrictions in Russia are expected to restrict the Company's ability to pay any further dividends until further notice. It remains the Company's intention to resume quarterly dividend payments once circumstances permit.

 

Share Buyback:

The Company will not be buying back shares whilst current market conditions prevail.

 

 

 

AGM:

The Board continues to recommend that shareholders vote in favour of the resolution for the continuation of the Company at the Annual General Meeting on 4th March 2022. The Board will monitor developments closely thereafter.

 

 

1st March 2022

 

For further information:

 

Paul Winship

Tim Mitchell

JPMorgan Funds Limited 020 7742 4000

 

Hugh Jonathan

Numis Securities plc 020 7260 1000

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDBSGDXCBGDGDB
Date   Source Headline
9th Feb 202211:20 amRNSNet Asset Value(s)
8th Feb 202211:03 amRNSNet Asset Value(s)
7th Feb 202212:43 pmRNSGearing Announcement
7th Feb 202212:15 pmRNSNet Asset Value(s)
4th Feb 202211:38 amRNSNet Asset Value(s)
3rd Feb 202211:29 amRNSNet Asset Value(s)
2nd Feb 202212:15 pmRNSNet Asset Value(s)
1st Feb 202211:26 amRNSNet Asset Value(s)
1st Feb 20229:00 amRNSTotal Voting Rights
31st Jan 202212:14 pmRNSGearing Announcement
31st Jan 202211:54 amRNSNet Asset Value(s)
28th Jan 20221:06 pmRNSHolding(s) in Company
28th Jan 202211:49 amRNSNet Asset Value(s)
27th Jan 202211:21 amRNSNet Asset Value(s)
27th Jan 20229:20 amRNSDividend Declaration
26th Jan 202212:02 pmRNSNet Asset Value(s)
26th Jan 202211:33 amRNSDirector/PDMR Shareholding
25th Jan 202211:58 amRNSNet Asset Value(s)
25th Jan 202211:06 amRNSFinal Results
24th Jan 20221:52 pmRNSGearing Announcement
24th Jan 20221:01 pmRNSNet Asset Value(s)
21st Jan 202212:28 pmRNSNet Asset Value(s)
20th Jan 202212:13 pmRNSNet Asset Value(s)
19th Jan 20224:26 pmRNSTransaction in Own Shares
19th Jan 202211:46 amRNSNet Asset Value(s)
18th Jan 202211:07 amRNSNet Asset Value(s)
17th Jan 202212:42 pmRNSTen Largest Investments
17th Jan 202211:52 amRNSGearing Announcement
17th Jan 202211:46 amRNSNet Asset Value(s)
14th Jan 202211:18 amRNSNet Asset Value(s)
13th Jan 20224:38 pmRNSTransaction in Own Shares
13th Jan 202210:53 amRNSNet Asset Value(s)
12th Jan 202210:39 amRNSNet Asset Value(s)
11th Jan 202210:58 amRNSNet Asset Value(s)
10th Jan 202211:47 amRNSGearing Announcement
10th Jan 202211:08 amRNSNet Asset Value(s)
7th Jan 202211:02 amRNSNet Asset Value(s)
6th Jan 202211:13 amRNSNet Asset Value(s)
5th Jan 202211:15 amRNSNet Asset Value(s)
4th Jan 20222:55 pmRNSTotal Voting Rights
4th Jan 20221:22 pmRNSGearing Announcement
4th Jan 20221:18 pmRNSNet Asset Value(s)
4th Jan 20229:37 amRNSDirectorate Change
31st Dec 202111:46 amRNSNet Asset Value(s)
30th Dec 20214:54 pmRNSTransaction in Own Shares
30th Dec 202111:04 amRNSNet Asset Value(s)
29th Dec 20214:18 pmRNSTransaction in Own Shares
29th Dec 202112:14 pmRNSGearing Announcement
29th Dec 202111:17 amRNSNet Asset Value(s)
24th Dec 202111:32 amRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.